Remedy Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing CIRARA, an innovative treatment for Large Hemispheric Infarction (LHI), a severe type of ischemic stroke
Remedy Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing CIRARA, an innovative treatment for Large Hemispheric Infarction (LHI), a severe type of ischemic stroke. The company aims to improve patient outcomes through its drug, which targets cerebral edema associated with LHI.